
Moderna beats Wall Street estimates for first-quarter profit and sales
By Patrick Wingrove (Reuters) -Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company’s cost-cutting efforts following waning post-pandemic demand for its COVID-19 vaccine. The U.S. vaccine maker also said it did not expect to get regulator approval for its combination shot to protect against both COVID-19 and influenza until 2026, afte ...